Accumulating evidence shows that IL-15 agents have some efficacy as monotherapy, but they have a great potential when used in combination with chemotherapy agents, resulting in enhanced NK cell activity against tumor recurrence and metastasis in animal models68. Here, IL15 is linked to neoplasm.